Form 4: ASP Isotopes CFO Executes Sell-to-Cover Transaction

CFO Heather Kiessling sold 23,124 shares of ASP Isotopes to satisfy tax obligations related to restricted stock vesting.

Summary

• Heather Kiessling, Chief Financial Officer of ASP Isotopes Inc., sold 23,124 shares of common stock on April 15, 2026.
• The transaction was executed at a weighted average price of $5.478 per share.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 19, 2025.
• Following the transaction, the reporting person retains beneficial ownership of 709,376 shares.
• The sale was specifically designated as a 'sell to cover' transaction to satisfy tax withholding obligations.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was a routine administrative action to cover tax obligations rather than a discretionary divestment.

Positives

• The transaction was non-discretionary, executed under a pre-established Rule 10b5-1 plan, indicating the sale was for tax compliance rather than a change in outlook.

Negatives

• The sale reduces the direct equity stake held by the CFO, though the reduction is marginal relative to total holdings.

Risks

• Market volatility could impact the value of remaining holdings, as evidenced by the price range of $5.12 to $5.71 observed during the sale.

Future Outlook

No forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are standard corporate practice for executives to manage tax liabilities associated with equity compensation and generally do not signal a lack of confidence in the company's future performance.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is a standard governance practice for executives to avoid potential conflicts of interest or accusations of insider trading.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was pre-planned and limited to tax coverage.

Next Steps

• No future operational milestones were disclosed in this filing.

Key Dates

Keywords

ASPI, ASP Isotopes, Insider Trading, Form 4, CFO, Sell to Cover